<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examined the effects of two stabilised analogues of TRH, RX 77368 and CG 3509, in a rat <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> model produced by unilateral occlusion of the middle cerebral artery </plain></SENT>
<SENT sid="1" pm="."><plain>The analogues were given intraventricularly after <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The extent of the cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> was evaluated after 10 days by somatosensory evoked potential (SEP) recording, followed by tetrazolium staining of brain slices for <z:chebi fb="0" ids="16908">NADH</z:chebi>-diaphorase activity </plain></SENT>
<SENT sid="3" pm="."><plain>RX 77368 (2 X 10 micrograms; 15 min, 24 h) significantly improved the survival rate, protected the SEP and reduced the area of <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, neither a smaller dose of RX 77368 (2 X 3 micrograms) nor a 4 h delay in the treatment had any significant beneficial effects </plain></SENT>
<SENT sid="5" pm="."><plain>Although CG 3509 (2 X 10 micrograms) resulted in an apparent improvement in survival, its overall effects were not statistically significant </plain></SENT>
<SENT sid="6" pm="."><plain>The findings indicate that stabilised TRH analogues may have beneficial effects when given to animals with focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
</text></document>